If You Had Bought Guangdong Kanghua Healthcare (HKG:3689) Stock A Year Ago, You’d Be Sitting On A 45% Loss, Today

In This Article:

It’s easy to match the overall market return by buying an index fund. But if you buy individual stocks, you can do both better or worse than that. For example, the Guangdong Kanghua Healthcare Co., Ltd. (HKG:3689) share price is down 45% in the last year. That contrasts poorly with the market return of -8.7%. Guangdong Kanghua Healthcare may have better days ahead, of course; we’ve only looked at a one year period. On top of that, the share price has dropped a further 8.4% in a month.

Check out our latest analysis for Guangdong Kanghua Healthcare

In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. One way to examine how market sentiment has changed over time is to look at the interaction between a company’s share price and its earnings per share (EPS).

Even though the Guangdong Kanghua Healthcare share price is down over the year, its EPS actually improved. It’s quite possible that growth expectations may have been unreasonable in the past. By glancing at these numbers, we’d posit that the the market had expectations of much higher growth, last year. But other metrics might shed some light on why the share price is down.

Guangdong Kanghua Healthcare’s revenue is actually up 16% over the last year. Since we can’t easily explain the share price movement based on these metrics, it might be worth considering how market sentiment has changed towards the stock.

Depicted in the graphic below, you’ll see revenue and earnings over time. If you want more detail, you can click on the chart itself.

SEHK:3689 Income Statement, March 10th 2019
SEHK:3689 Income Statement, March 10th 2019

You can see how its balance sheet has strengthened (or weakened) over time in this free interactive graphic.

A Different Perspective

We doubt Guangdong Kanghua Healthcare shareholders are happy with the loss of 44% over twelve months (even including dividends). That falls short of the market, which lost 8.7%. There’s no doubt that’s a disappointment, but the stock may well have fared better in a stronger market. The share price decline has continued throughout the most recent three months, down 2.5%, suggesting an absence of enthusiasm from investors. Basically, most investors should be wary of buying into a poor-performing stock, unless the business itself has clearly improved. If you would like to research Guangdong Kanghua Healthcare in more detail then you might want to take a look at whether insiders have been buying or selling shares in the company.

Of course Guangdong Kanghua Healthcare may not be the best stock to buy. So you may wish to see this free collection of growth stocks.